Go offline with the Player FM app!
Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D.
Manage episode 393432068 series 2908385
Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost cardiovascular risk.
Show notes
(00:31)
Could you provide us a little bit about your background?
(01:20)
Could you give us a brief overview of this assay?
(02:45)
What patients should have this test and when should it be performed?
(04:25)
Could you talk a little bit about alternative test options and how they compare to our ceramides test?
(05:58)
Can you go a little bit further into how these results can impact patient care and how you may monitor patients in the future with this testing?
308 episodes
Manage episode 393432068 series 2908385
Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost cardiovascular risk.
Show notes
(00:31)
Could you provide us a little bit about your background?
(01:20)
Could you give us a brief overview of this assay?
(02:45)
What patients should have this test and when should it be performed?
(04:25)
Could you talk a little bit about alternative test options and how they compare to our ceramides test?
(05:58)
Can you go a little bit further into how these results can impact patient care and how you may monitor patients in the future with this testing?
308 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.